These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23371316)

  • 21. L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy.
    Jalan R; Wright G; Davies NA; Hodges SJ
    Med Hypotheses; 2007; 69(5):1064-9. PubMed ID: 17467190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Branched chain amino acids in heptatic encephalopathy.
    James JH
    Am J Surg; 2002 Apr; 183(4):424-9. PubMed ID: 11975931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New strategies for treating hepatic encephalopathy.
    Gómez-Gutiérrez C; Manzano-Robleda MC; Uribe M; Méndez-Sánchez N
    Ann Hepatol; 2014; 13(3):409-11. PubMed ID: 24756021
    [No Abstract]   [Full Text] [Related]  

  • 24. Supplementation with Synbiotics and/or Branched Chain Amino Acids in Hepatic Encephalopathy: A Pilot Randomised Placebo-Controlled Clinical Study.
    Vidot H; Cvejic E; Finegan LJ; Shores EA; Bowen DG; Strasser SI; McCaughan GW; Carey S; Allman-Farinelli M; Shackel NA
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31390762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced cerebral branched-chain amino acid metabolism in R6/2 mouse model of Huntington's disease.
    Andersen JV; Skotte NH; Aldana BI; Nørremølle A; Waagepetersen HS
    Cell Mol Life Sci; 2019 Jun; 76(12):2449-2461. PubMed ID: 30830240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiological and pathological roles of branched-chain amino acids in the regulation of protein and energy metabolism and neurological functions.
    Shimomura Y; Kitaura Y
    Pharmacol Res; 2018 Jul; 133():215-217. PubMed ID: 29803540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Which of the branched-chain amino acids increases cerebral blood flow in hepatic encephalopathy? A double-blind randomized trial.
    Romeiro FG; Ietsugu MDV; Franzoni LC; Augusti L; Alvarez M; Santos LAA; Lima TB; Koga KH; Moriguchi SM; Caramori CA; Silva GF; Betting LEGG
    Neuroimage Clin; 2018; 19():302-310. PubMed ID: 30013913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ammonia and amino acid profiles in liver cirrhosis: effects of variables leading to hepatic encephalopathy.
    Holecek M
    Nutrition; 2015 Jan; 31(1):14-20. PubMed ID: 25220875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The anaplerotic flux and ammonia detoxification in hepatic encephalopathy.
    Zwingmann C
    Metab Brain Dis; 2007 Dec; 22(3-4):235-49. PubMed ID: 17823857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amino acid metabolism in patients with propionic acidaemia.
    Scholl-Bürgi S; Sass JO; Zschocke J; Karall D
    J Inherit Metab Dis; 2012 Jan; 35(1):65-70. PubMed ID: 21113738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute hyperammonemia activates branched-chain amino acid catabolism and decreases their extracellular concentrations: different sensitivity of red and white muscle.
    Holecek M; Kandar R; Sispera L; Kovarik M
    Amino Acids; 2011 Feb; 40(2):575-84. PubMed ID: 20614225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism of branched-chain amino acids and ammonia during exercise: clues from McArdle's disease.
    Wagenmakers AJ; Coakley JH; Edwards RH
    Int J Sports Med; 1990 May; 11 Suppl 2():S101-13. PubMed ID: 2193889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of Branched Chain Amino Acids in the treatment of hepatic Encephalopathy.
    Dam G; Aamann L; Vistrup H; Gluud LL
    J Clin Exp Hepatol; 2018 Dec; 8(4):448-451. PubMed ID: 30568347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Branch-chain amino acids: their metabolism and clinical utility.
    Skeie B; Kvetan V; Gil KM; Rothkopf MM; Newsholme EA; Askanazi J
    Crit Care Med; 1990 May; 18(5):549-71. PubMed ID: 2158415
    [No Abstract]   [Full Text] [Related]  

  • 35. Ammonia-lowering strategies for the treatment of hepatic encephalopathy.
    Rose CF
    Clin Pharmacol Ther; 2012 Sep; 92(3):321-31. PubMed ID: 22871998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three targets of branched-chain amino acid supplementation in the treatment of liver disease.
    Holecek M
    Nutrition; 2010 May; 26(5):482-90. PubMed ID: 20071143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infusion of branched-chain enriched amino acid solution in patients with hepatic encephalopathy.
    Freund H; Dienstag J; Lehrich J; Yoshimura N; Bradford RR; Rosen H; Atamian S; Slemmer E; Holroyde J; Fischer JE
    Ann Surg; 1982 Aug; 196(2):209-20. PubMed ID: 6284073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infusion of the branched chain amino acids in postoperative patients. Anticatabolic properties.
    Freund H; Hoover HC; Atamian S; Fischer JE
    Ann Surg; 1979 Jul; 190(1):18-23. PubMed ID: 464673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy.
    Rockey DC; Vierling JM; Mantry P; Ghabril M; Brown RS; Alexeeva O; Zupanets IA; Grinevich V; Baranovsky A; Dudar L; Fadieienko G; Kharchenko N; Klaryts'ka I; Morozov V; Grewal P; McCashland T; Reddy KG; Reddy KR; Syplyviy V; Bass NM; Dickinson K; Norris C; Coakley D; Mokhtarani M; Scharschmidt BF;
    Hepatology; 2014 Mar; 59(3):1073-83. PubMed ID: 23847109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of Glutamate and Glutamine Transport in Ammonia Neurotoxicity: State of the Art and Question Marks.
    Dabrowska K; Skowronska K; Popek M; Obara-Michlewska M; Albrecht J; Zielinska M
    Endocr Metab Immune Disord Drug Targets; 2018; 18(4):306-315. PubMed ID: 29256360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.